Prokinetic effects of a new ghrelin receptor agonist TZP-101 in a rat model of postoperative ileus.

Article Details

Citation
Copy to clipboard

Venkova K, Fraser G, Hoveyda HR, Greenwood-Van Meerveld B

Prokinetic effects of a new ghrelin receptor agonist TZP-101 in a rat model of postoperative ileus.

Dig Dis Sci. 2007 Sep;52(9):2241-8. Epub 2007 Apr 10.

PubMed ID
17436082 [ View in PubMed
]
Abstract

Postoperative ileus (POI) is a major cause of postoperative complications and prolonged hospitalization. Ghrelin, which is the endogenous ligand for the growth hormone secretagogue receptor, has been found to stimulate gastric motility and accelerate gastric emptying. The present study investigates whether TZP-101 (0.03-1 mg/kg i.v.), a synthetic ghrelin-receptor agonist, could improve gastrointestinal transit in rats with POI. Since the main factors for the development of POI are the surgical manipulation and the gastrointestinal effects of opioid-receptor agonists used for pain management, the effect of TZP-101 was investigated in rats subjected to surgery, to morphine treatment (3 mg/kg s.c.), or to a combination of both. The results showed that TZP-101 is equally effective against the delayed gastrointestinal transit induced by surgery, by morphine, or by the combination of both interventions. The prokinetic action of TZP-101 was more pronounced in the stomach compared to the small intestine.

DrugBank Data that Cites this Article

Drugs
Drug Targets
DrugTargetKindOrganismPharmacological ActionActions
UlimorelinGrowth hormone secretagogue receptor type 1ProteinHumans
Unknown
Not AvailableDetails